HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Growing Social Media Use Justifies Higher Online Ad Spend

This article was originally published in The Tan Sheet

Executive Summary

OTC firms should provide messaging across multiple channels, including social networks, Facebook, Twitter, Google+ and other platforms, says Google executive Michelle Schumaker. But traditional ads can link consumers to web sites as more watch TV on devices other than televisions, says Rick Mandler, of ABC.

You may also be interested in...



Colgate Boosts Digital Marketing Spend, Trims Product Line

Colgate has 45 Facebook pages for all its brands and is building digital marketing programs in partnerships with Microsoft, Yahoo! and Amazon.com. The firm trims its product lineup as part of the ongoing stock-keeping unit-reduction program within its cost-savings initiative focused on increasing efficiency.

Social Media Success Prompts Anti Monkey Butt To Turn Its Back On TV

DSE Healthcare Solutions, purveyor of the anti-chafing Anti Monkey Butt line, pulled out of TV advertising after social media proved more effective.

Social Media Marketing Guidance Available In Existing Regs, Experts Say

Firms waiting for FDA to issue guidance on how best to use social media for marketing and promotion can look instead at existing regulations both in and outside the agency, experts said recently.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124753

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel